We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
+$660M
Cap. Flow
+$542M
Cap. Flow %
18.28%
Top 10 Hldgs %
31.64%
Holding
3,611
New
266
Increased
1,484
Reduced
936
Closed
189
Avg Time Held Equity + Options
3.4 years
Top 10 Avg Time Held Equity + Options
2 years
Top 20 Avg Time Held Equity + Options
2.3 years
Avg Time Held Equity only
3.5 years
Top 10 Avg Time Held Equity only
2 years
Top 20 Avg Time Held Equity only
2.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.73%
2 Technology 13.87%
3 Healthcare 8.82%
4 Financials 7.01%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PSFE icon
3001
Paysafe
PSFE
$296M
$812 ﹤0.01%
47
+35
+292% +$681
2022 Q4
1 quarter
EMQQ icon
3002
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$237M
$802 ﹤0.01%
25
-473
-95% -$15.3K
2020 Q3
10 quarters
SIGA icon
3003
SIGA Technologies
SIGA
$228M
$799 ﹤0.01%
+139
New +$929
2023 Q1
0 quarters
EBS icon
3004
Emergent Biosolutions
EBS
$327M
$798 ﹤0.01%
77
– –
2020 Q4
9 quarters
FLNA icon
3005
Filana Therapeutics
FLNA
$34M
$796 ﹤0.01%
33
+23
+230% +$637
2021 Q1
8 quarters
GDXJ icon
3006
VanEck Junior Gold Miners ETF
GDXJ
$8.14B
$790 ﹤0.01%
20
-692
-97% -$25.6K
2016 Q4
25 quarters
ARRY icon
3007
Array Technologies
ARRY
$528M
$788 ﹤0.01%
36
– –
2021 Q2
7 quarters
PCVX icon
3008
Vaxcyte
PCVX
$10B
$787 ﹤0.01%
21
-6
-22% -$255
2022 Q3
2 quarters
HELP
3009
Helus Pharma Inc. Common Stock
HELP
$771M
$783 ﹤0.01%
+53
New +$859
2023 Q1
0 quarters
FLWS icon
3010
1-800-Flowers.com
FLWS
$177M
$771 ﹤0.01%
67
-130
-66% -$1.33K
2020 Q2
11 quarters
OPLN icon
3011
Openlane
OPLN
$4.52B
$766 ﹤0.01%
56
– –
2017 Q1
24 quarters
DFAI icon
3012
Dimensional International Core Equity Market ETF
DFAI
$18B
$755 ﹤0.01%
28
– –
2022 Q1
4 quarters
CTLP icon
3013
DELISTED
Cantaloupe
CTLP
$752 ﹤0.01%
132
– –
2022 Q2
3 quarters
GTX icon
3014
Garrett Motion
GTX
$4.56B
$751 ﹤0.01%
98
– –
2021 Q3
6 quarters
NEXT icon
3015
NextDecade
NEXT
$1.67B
$750 ﹤0.01%
151
+117
+344% +$680
2022 Q4
1 quarter
ONL icon
3016
Orion Office REIT
ONL
$118M
$750 ﹤0.01%
112
-23
-17% -$187
2022 Q1
4 quarters
FIX icon
3017
Comfort Systems
FIX
$50.6B
$744 ﹤0.01%
5
– –
2020 Q2
11 quarters
CMTL icon
3018
Comtech Telecommunications
CMTL
$41.6M
$736 ﹤0.01%
59
– –
2021 Q1
8 quarters
EVO icon
3019
Evotec
EVO
$490M
$732 ﹤0.01%
70
– –
2022 Q1
4 quarters
OPRX icon
3020
OptimizeRx
OPRX
$160M
$732 ﹤0.01%
50
– –
2022 Q4
1 quarter
NSP icon
3021
Insperity
NSP
$1.96B
$729 ﹤0.01%
6
+5
+500% +$585
2021 Q2
7 quarters
AGNT icon
3022
AGNT Inc
AGNT
$640M
$723 ﹤0.01%
57
-183
-76% -$2.44K
2021 Q3
6 quarters
ADVM icon
3023
DELISTED
Adverum Biotechnologies
ADVM
$717 ﹤0.01%
100
– –
2020 Q1
12 quarters
PFSI icon
3024
PennyMac Financial
PFSI
$3.13B
$715 ﹤0.01%
12
– –
2021 Q4
5 quarters
DNLI icon
3025
Denali Therapeutics
DNLI
$2.81B
$714 ﹤0.01%
+31
New +$853
2023 Q1
0 quarters

Similar funds

Parallel Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Parallel Advisors held 3,611 positions worth $2.97B, up 29% from $2.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors deployed $542M of net new capital in Q1 2023, opening 266 new positions and adding to 1,484 existing holdings. Its largest new stake was Vanguard International Dividend Appreciation ETF: 74,827 shares worth $5.51M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 54% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street Energy Select Sector SPDR ETF, an estimated $21.8M trimmed.

  • Parallel Advisors's largest Q1 2023 buy was Vanguard International Dividend Appreciation ETF: 74,827 shares worth $5.51M.
  • Parallel Advisors added most to iShares 0-1 Year Treasury Bond ETF in Q1 2023, an estimated $38.1M increase.
  • Parallel Advisors's biggest Q1 2023 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $21.8M.
  • Parallel Advisors fully exited 1Life Healthcare in Q1 2023, selling an estimated $1.96M.
  • Parallel Advisors's ten largest holdings make up 32% of its $2.97B portfolio in Q1 2023.
  • Parallel Advisors opened 266 new positions and closed 189 in Q1 2023.
  • Parallel Advisors's portfolio value rose 29% quarter-over-quarter to $2.97B.

Based on Parallel Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.